The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-α

[1]  G. Dusheiko.  Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[2]  C. Brander,et al.  Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. , 2013, Journal of hepatology.

[3]  M. Dandri,et al.  Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B? , 2013, Journal of hepatology.

[4]  E. Yu,et al.  Effect of Response to Interferon-α Therapy on the Occurrence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B , 2012, Digestive Diseases.

[5]  P. MacAry,et al.  Targeted delivery of interferon‐α to hepatitis B virus‐infected cells using T‐cell receptor‐like antibodies , 2012, Hepatology.

[6]  G. Cheng,et al.  Poly I:C Enhances Susceptibility to Secondary Pulmonary Infections by Gram-Positive Bacteria , 2012, PloS one.

[7]  M. Dandri,et al.  New insight in the pathobiology of hepatitis B virus infection , 2012, Gut.

[8]  Hao Wu,et al.  Potent hepatitis B surface antigen response to treatment of hepatitis‐B‐e‐antigen‐positive chronic hepatitis B with α‐interferon plus a nucleos(t)ide analog , 2012, Journal of gastroenterology and hepatology.

[9]  Qiuju Han,et al.  Involvement of Activation of PKR in HBx-siRNA-Mediated Innate Immune Effects on HBV Inhibition , 2011, PloS one.

[10]  M. Yuen,et al.  Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B. , 2011, The Journal of antimicrobial chemotherapy.

[11]  E. Keeffe,et al.  Review article: current antiviral therapy of chronic hepatitis B , 2011, Alimentary pharmacology & therapeutics.

[12]  Z. Tian,et al.  Ectopic expression of microRNA-155 enhances innate antiviral immunity against HBV infection in human hepatoma cells , 2011, Virology Journal.

[13]  T. Karlıdağ,et al.  The effects of pegylated interferon/lamivudine therapy on auditory functions in patients with chronic hepatitis B. , 2011, Auris, nasus, larynx.

[14]  H. Yoo,et al.  MMPs-responsive release of DNA from electrospun nanofibrous matrix for local gene therapy: in vitro and in vivo evaluation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Y. Naomoto,et al.  Adenovirus-mediated cancer gene therapy and virotherapy (Review). , 2009, International journal of molecular medicine.

[16]  M. Ghany,et al.  Antiviral resistance and hepatitis B therapy , 2009, Hepatology.

[17]  J. Prieto,et al.  Treatment of Chronic Viral Hepatitis in Woodchucks by Prolonged Intrahepatic Expression of Interleukin-12 , 2008, Journal of Virology.

[18]  H. Janssen,et al.  Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues. , 2008, Best practice & research. Clinical gastroenterology.

[19]  Bryan R. G. Williams,et al.  Interferon-inducible antiviral effectors , 2008, Nature Reviews Immunology.

[20]  L. van der Fits,et al.  IFN-alpha enhances poly-IC responses in human keratinocytes by inducing expression of cytosolic innate RNA receptors: relevance for psoriasis. , 2008, The Journal of investigative dermatology.

[21]  N. Nikolaidis,et al.  Lamivudine/pegylated interferon alfa‐2b sequential combination therapy compared with lamivudine monotherapy in HBeAg‐negative chronic hepatitis B , 2007, Journal of gastroenterology and hepatology.

[22]  D. Levy,et al.  JAK-STAT Signaling: From Interferons to Cytokines* , 2007, Journal of Biological Chemistry.

[23]  T. Asselah,et al.  Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[24]  D. Glebe.  Recent advances in hepatitis B virus research: a German point of view. , 2007, World journal of gastroenterology.

[25]  Shizuo Akira,et al.  Antiviral signaling through pattern recognition receptors. , 2006, Journal of biochemistry.

[26]  R. Guan.  Treatment of chronic hepatitis B infection using interferon. , 2005, The Medical journal of Malaysia.

[27]  G. Gerken,et al.  The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation , 2005, Alimentary pharmacology & therapeutics.

[28]  B. Pützer,et al.  Helper-Dependent Adenoviral Vector-Mediated Delivery of Woodchuck-Specific Genes for Alpha Interferon (IFN-α) and IFN-γ: IFN-α but Not IFN-γ Reduces Woodchuck Hepatitis Virus Replication in Chronic Infection In Vivo , 2004, Journal of Virology.

[29]  M. Morilla,et al.  Intravenous liposomal benznidazole as trypanocidal agent: increasing drug delivery to liver is not enough. , 2004, International journal of pharmaceutics.

[30]  Chutima Pramoolsinsup.  Management of viral hepatitis B , 2002, Journal of gastroenterology and hepatology.

[31]  A. García-Sastre,et al.  VIRUSES AND THE TYPE I INTERFERON ANTIVIRAL SYSTEM: INDUCTION AND EVASION , 2002, International reviews of immunology.

[32]  J. Villeneuve,et al.  Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B , 2000, Hepatology.

[33]  H. Ezelle,et al.  A central role for RNA in the induction and biological activities of type 1 interferons , 2011, Wiley interdisciplinary reviews. RNA.

[34]  G. Foti,et al.  Effectiveness of add-on pegylated interferon alfa-2a therapy in a lamivudine-treated patient with chronic hepatitis B. , 2011, Annals of hepatology.

[35]  W. Jiang,et al.  Functional characterization of interleukin-15 gene transduction into the human natural killer cell line NKL. , 2008, Cytotherapy.

[36]  B. Pützer,et al.  Helper-dependent adenoviral vector-mediated delivery of woodchuck-specific genes for alpha interferon (IFN-alpha) and IFN-gamma: IFN-alpha but not IFN-gamma reduces woodchuck hepatitis virus replication in chronic infection in vivo. , 2004, Journal of virology.

[37]  L. Wang,et al.  Virology Journal , 1966, Nature.